Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOPOROSIS, POSTMENOPAUSAL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00532246
What this trial is testing

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 147
Testing effectiveness (Phase 2)Study completedNCT06843486
What this trial is testing

SB: Promoting Bone Health in Women

Who this might be right for
Osteoporosis
Instituto Politécnico de Bragança 40
Post-approval studies (Phase 4)Study completedNCT02576652
What this trial is testing

Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement

Who this might be right for
Osteoporosis
Amgen 6
Not applicableStudy completedNCT01881204
What this trial is testing

Hesperidin and Bone Health in Postmenopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
Purdue University 12
Not applicableStudy completedNCT03931109
What this trial is testing

Circulating miRNA in Primary Hyperparathyroidism

Who this might be right for
Primary HyperparathyroidismOsteoporosis, Postmenopausal
University of Pennsylvania 96
Early research (Phase 1)Study completedNCT00965978
What this trial is testing

Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

Who this might be right for
OsteoporosisOsteoporosis, PostmenopausalBone Diseases
Astellas Pharma Inc 48
Not applicableNot Yet RecruitingNCT07519551
What this trial is testing

Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength

Who this might be right for
Osteoporosis, Osteopenia
Kanuni Sultan Suleyman Training and Research Hospital 60
Large-scale testing (Phase 3)Study completedNCT00046137
What this trial is testing

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company
Post-approval studies (Phase 4)Study completedNCT00081653
What this trial is testing

Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva

Who this might be right for
Post-Menopausal Osteoporosis
Hoffmann-La Roche 719
Large-scale testing (Phase 3)Study completedNCT00383422
What this trial is testing

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 320
Large-scale testing (Phase 3)UnknownNCT05305183
What this trial is testing

A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis
Shandong New Time Pharmaceutical Co., LTD 330
Early research (Phase 1)Study completedNCT03925051
What this trial is testing

Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers

Who this might be right for
Postmenopausal Osteoporosis
Shanghai Biomabs Pharmaceutical Co., Ltd. 132
Post-approval studies (Phase 4)Study completedNCT00927186
What this trial is testing

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

Who this might be right for
Osteoporosis, Post-menopausal
Eli Lilly and Company 69
Large-scale testing (Phase 3)Study completedNCT00354302
What this trial is testing

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Who this might be right for
Breast CancerOsteoporosis
NCIC Clinical Trials Group 497
Not applicableUnknownNCT05405894
What this trial is testing

Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation

Who this might be right for
OsteoporosisOsteoporosis, PostmenopausalOsteopenia+1 more
University of Calgary 20
Early research (Phase 1)Study completedNCT00770159
What this trial is testing

Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)

Who this might be right for
Osteoporosis
Merck Sharp & Dohme LLC 78
Post-approval studies (Phase 4)Study completedNCT00745485
What this trial is testing

Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid

Who this might be right for
Osteoporosis
Novartis Pharmaceuticals 186
Large-scale testing (Phase 3)Study completedNCT00718861
What this trial is testing

3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

Who this might be right for
Post-menopausal Osteoporosis
Novartis Pharmaceuticals 190
Large-scale testing (Phase 3)Study completedNCT05067335
What this trial is testing

Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis

Who this might be right for
Osteoporosis
UCB Biopharma SRL 327
Large-scale testing (Phase 3)Study completedNCT00088010
What this trial is testing

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 9,369
Next Page